[Syndrome of catecholamine hypersecretion secondary to a jejuno-ileal bypass].
Hypersecretion of catecholamine primarily affecting adrenaline levels arose in a patient given a jejunoileal bypass for severe obesity. Apart from organic factors, including a hetero and/or orthotopic pheochromocytoma and the therapeutic effect of beta-blocking drugs, it is suggested that the pathogenesis of the patient's condition is based on a hypersecretion of VIP, as sometimes occurs in patients with short intestine/syndrome.
D000328:Adult; D002395:Catecholamines / Q000652:urine; D004837:Epinephrine / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007581:Jejunoileal Bypass / Q000009:adverse effects*; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000628:therapy; D010673:Pheochromocytoma / Q000150:complications / Q000503:physiopathology; D013217:Starvation; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
D002395:Catecholamines; D014660:Vasoactive Intestinal Peptide; D009638:Norepinephrine; D004837:Epinephrine
Sindrome da iperincrezione catecolaminica secondaria a by-pass digiuno-ileale.